GLOW BPC-157 / TB-500 / GHK-Cu (10mg / 10mg / 50mg)
For Research Use Only — Not for Human Use
Intended for laboratory research use only (e.g., analytical and in-vitro studies). Not for human use.
This research blend combines three widely studied peptides: BPC-157, TB-500, and GHK-Cu.
Each compound has been individually investigated for its interactions with biological pathways related to cellular repair, structural tissue regulation, angiogenesis, and inflammatory signaling.
Together, this combination is used in laboratory settings to explore how multiple signaling mechanisms behave when studied simultaneously.
GENIQ provides this blend strictly for scientific research—not for human or animal use.
$239.99
-
Official retailer -
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is BPC-157 / TB-500 / GHK-Cu?
This research blend combines three widely studied peptides: BPC-157, TB-500, and GHK-Cu.
Each compound has been individually investigated for its interactions with biological pathways related to cellular repair, structural tissue regulation, angiogenesis, and inflammatory signaling.
Together, this combination is used in laboratory settings to explore how multiple signaling mechanisms behave when studied simultaneously.
GENIQ provides this blend strictly for scientific research—not for human or animal use.
Peptide Overview
This formulation integrates three peptides with distinct research profiles:
BPC-157: A 15-amino-acid fragment examined for potential influences on inflammatory signaling, cellular migration, and tissue-modulation pathways.
TB-500 (Thymosin Beta-4 Fragment): A synthetic peptide modeled after a region of thymosin beta-4, studied for its associations with cytoskeletal organization, angiogenesis, and tissue recovery dynamics.
GHK-Cu: A copper-binding tripeptide (Gly-His-Lys-Cu) studied for its effects on wound environments, cellular signaling, collagen-related processes, and gene-expression changes observed in research models.
In research environments, the combination is examined to understand how these peptides together may promote changes in:
| Tissue-regulation responses |
| Angiogenic pathways |
| Fibroblast activity |
| Inflammatory mediator behavior |
| Extracellular matrix dynamics |
| Gene and protein signaling associated with cellular remodeling |
| These observations reflect laboratory data only. |
All findings remain limited to preclinical and in-vitro experimental environments.
History of the BPC-157 / TB-500 / GHK-Cu Blend
BPC-157 emerged from research on gastric-protective proteins and their regulatory influence on tissue-repair environments.
TB-500 originates from studies on thymosin beta-4, a protein associated with injury-response coordination and cytoskeletal organization.
GHK-Cu was discovered in the 1970s in human plasma and has since been studied for its relationship to wound pathways, collagen processes, and cellular regulatory signals.
| Over time, experimental researchers combined these peptides to explore how they interact when studied simultaneously, especially in models involving tissue remodeling mechanisms, angiogenic signaling, and inflammatory regulation. This combination remains exclusively a research tool used in controlled laboratory conditions. |
Peptide Structure
BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-LeuTB-500 Fragment Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-LysGHK-Cu Sequence: Gly-His-Lys (with copper binding)
Certificates of Analysis
BPC-157 / TB-500 / GHK-Cu (10mg / 10mg / 50mg)
Research Findings
Research focusing on this triple-peptide blend explores multiple biological areas:
| Angiogenic activity: Studies investigate how endothelial cells respond to the peptides individually and in combination. |
| Inflammation modulation: Research examines changes in inflammatory markers and tissue communication. |
| Fibroblast and extracellular matrix models: Investigations explore how cells involved in structural repair respond under laboratory conditions. |
| Gene-related pathways: GHK-Cu is frequently studied for its influence on genes associated with collagen, remodeling, and skin regeneration models. |
| Cytoskeletal and tissue structure regulation: TB-500–related research often examines actin dynamics and tissue-architecture processes. |
| All findings reflect controlled experimental environments and do not indicate clinical outcomes or medical effects. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Chang C. H., et al. “TB-500 fragment and its influence on cytoskeletal regulation and angiogenic response.” Peptide Science Review.
3. Pickart L., et al. “Characterization of GHK-Cu and its role in gene expression and tissue remodeling.” Biochemical Insights.
FAQ
Are GENIQ peptides pharmaceutical products?
No. They are not drugs, supplements, or therapeutic items. All compounds are provided strictly for laboratory research.
Who should purchase GENIQ research materials?
Qualified researchers, laboratories, and institutions working within applicable laws and regulations.
Do orders include COAs?
Yes. Each peptide includes a Certificate of Analysis confirming identity and purity testing when available for that lot.
What handling notes does GENIQ provide?
Only storage temperature and solvent-compatibility notes when listed on the product page. GENIQ does not provide guidance on preparation or application. Buyers follow their institution’s laboratory protocols.
Are these products for human use?
No. For Research Use Only — Not for Human Use. Not for human or animal consumption.
For Research Use Only — Not for Human Use
Sold exclusively as laboratory research materials. Not for human or animal consumption, clinical use, or household use.
Intended research use: Laboratory and in-vitro research, including analytical characterization and pathway / receptor-binding studies as applicable to this compound. Not for human consumption, clinical use, or diagnostic use on humans.
This research blend combines three widely studied peptides: BPC-157, TB-500, and GHK-Cu.
Each compound has been individually investigated for its interactions with biological pathways related to cellular repair, structural tissue regulation, angiogenesis, and inflammatory signaling.
Together, this combination is used in laboratory settings to explore how multiple signaling mechanisms behave when studied simultaneously.
GENIQ provides this blend strictly for scientific research—not for human or animal use.
